Aaron N. Winn

2.8k total citations · 1 hit paper
103 papers, 2.0k citations indexed

About

Aaron N. Winn is a scholar working on Economics and Econometrics, General Health Professions and Family Practice. According to data from OpenAlex, Aaron N. Winn has authored 103 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Economics and Econometrics, 14 papers in General Health Professions and 14 papers in Family Practice. Recurrent topics in Aaron N. Winn's work include Health Systems, Economic Evaluations, Quality of Life (25 papers), Economic and Financial Impacts of Cancer (15 papers) and Pharmaceutical Economics and Policy (13 papers). Aaron N. Winn is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (25 papers), Economic and Financial Impacts of Cancer (15 papers) and Pharmaceutical Economics and Policy (13 papers). Aaron N. Winn collaborates with scholars based in United States, United Kingdom and Australia. Aaron N. Winn's co-authors include Stacie B. Dusetzina, Nancy L. Keating, Haiden A. Huskamp, Gregory A. Abel, Elbert S. Huang, Peter J. Neumann, Joshua T. Cohen, Pei‐Jung Lin, Priya M. John and Aaron Philip Mitchell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aaron N. Winn

92 papers receiving 1.9k citations

Hit Papers

Cost Sharing and Adherence to Tyrosine Kinase Inhibitors ... 2013 2026 2017 2021 2013 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
    2013 389 citations Stacie B. Dusetzina, Aaron N. Winn et al. profile →

Peers

Aaron N. Winn
Mahesh Fuldeore United States
Wenke Hwang United States
Anuja Roy United States
Anita Burrell United States
Gérard de Pouvourville France
Gregory S. Calip United States
Angie Mae Rodday United States
Neil Wintfeld United States
Roberta Ara United Kingdom
Sue Ward United Kingdom
Mahesh Fuldeore United States
Aaron N. Winn
Citations per year, relative to Aaron N. Winn Aaron N. Winn (= 1×) peers Mahesh Fuldeore

Countries citing papers authored by Aaron N. Winn

Since Specialization
Citations

This map shows the geographic impact of Aaron N. Winn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron N. Winn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron N. Winn more than expected).

Fields of papers citing papers by Aaron N. Winn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron N. Winn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron N. Winn. The network helps show where Aaron N. Winn may publish in the future.

Co-authorship network of co-authors of Aaron N. Winn

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron N. Winn. A scholar is included among the top collaborators of Aaron N. Winn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron N. Winn. Aaron N. Winn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitchell, Aaron Philip, Stacie B. Dusetzina, Hannah E. Fuchs, et al.. (2025). Provider billing margin and cancer treatment selection: population based cohort study. BMJ. 391. e084729–e084729.
2.
Check, Devon K., Samir Soneji, Harvey Jay Cohen, et al.. (2025). Association of opioid and benzodiazepine coprescribing with adverse events among older adults with cancer. JNCI Journal of the National Cancer Institute. 117(7). 1465–1473. 1 indexed citations
3.
4.
Neuner, Joan, et al.. (2024). Developing a urinary incontinence primary care pathway: a mixed methods study. Family Practice. 41(5). 798–806.
5.
Winn, Aaron N., Anirban Basu, & Scott D. Ramsey. (2023). A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America. PharmacoEconomics - Open. 7(2). 313–320. 3 indexed citations
6.
Gopalan, Anjali, Aaron N. Winn, Andrew J. Karter, & Neda Laiteerapong. (2022). Racial and Ethnic Differences in Medication Initiation Among Adults Newly Diagnosed with Type 2 Diabetes. Journal of General Internal Medicine. 38(4). 994–1000.
7.
Check, Devon K., Christopher D. Baggett, KyungSu Kim, et al.. (2022). Concurrent prescribing of opioids with other sedating medications after cancer diagnosis: a population-level analysis. Supportive Care in Cancer. 30(12). 9781–9791. 5 indexed citations
8.
Staab, Erin M., Wen Wan, M. Reza Skandari, et al.. (2021). Longer-term Benefits and Risks of Sodium-Glucose Cotransporter-2 Inhibitors in Type 2 Diabetes: a Systematic Review and Meta-analysis. Journal of General Internal Medicine. 37(2). 439–448. 8 indexed citations
9.
Seymour, Erlene, Julie J. Ruterbusch, Aaron N. Winn, et al.. (2020). The costs of treating and not treating patients with chronic myeloid leukemia with tyrosine kinase inhibitors among Medicare patients in the United States. Cancer. 127(1). 93–102. 4 indexed citations
10.
Look, Kevin A., et al.. (2020). Trends in a State Pharmaceutical Assistance Program for Low-income Older Adults in Wisconsin. SHILAP Revista de lepidopterología. 11(4). 9–9. 2 indexed citations
11.
Check, Devon K., Aaron N. Winn, Nicole Fergestrom, et al.. (2019). Concurrent Opioid and Benzodiazepine Prescriptions Among Older Women Diagnosed With Breast Cancer. JNCI Journal of the National Cancer Institute. 112(7). 765–768. 7 indexed citations
12.
Anderson, Chelsea, Aaron N. Winn, Stacie B. Dusetzina, & Hazel B. Nichols. (2017). Endocrine Therapy Initiation among Older Women with Ductal Carcinoma In Situ. SHILAP Revista de lepidopterología. 2017. 1–6. 5 indexed citations
13.
Winn, Aaron N., et al.. (2017). The Role of the FDA and Regulatory Approval of New Devices for Diabetes Care. Current Diabetes Reports. 17(6). 40–40. 6 indexed citations
14.
Shah, Gunjan L., Aaron N. Winn, Anita J. Kumar, et al.. (2016). The Utility of the Charlson Comorbidity Index in Predicting Use of Treatment and Survival in Older Lymphoma Patients. Blood. 128(22). 2405–2405. 2 indexed citations
15.
Winn, Aaron N., Donatus U. Ekwueme, Gery P. Guy, & Peter J. Neumann. (2015). Cost-Utility Analysis of Cancer Prevention, Treatment, and Control. American Journal of Preventive Medicine. 50(2). 241–248. 43 indexed citations
16.
Chambers, James D., Huseyin Naci, Olivier J. Wouters, et al.. (2015). An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review. PLoS ONE. 10(4). e0121715–e0121715. 27 indexed citations
17.
Zhong, Yue, Pei‐Jung Lin, Joshua T. Cohen, Aaron N. Winn, & Peter J. Neumann. (2015). Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence. Value in Health. 18(2). 308–314. 23 indexed citations
18.
Olchanski, Natalia, Aaron N. Winn, Joshua T. Cohen, & Peter J. Neumann. (2013). Abdominal Aortic Aneurysm Screening: How Many Life Years Lost From Underuse Of The Medicare Screening Benefit?. Value in Health. 16(3). A210–A210. 1 indexed citations
19.
Smith, Chris, Aaron N. Winn, Paul Seddon, & Sarath Ranganathan. (2011). A fat lot of good: Balance and trends in fat intake in children with cystic fibrosis. Journal of Cystic Fibrosis. 11(2). 154–157. 25 indexed citations
20.
Lee, Joyce M., Michael J. O’Grady, Anirban Basu, et al.. (2011). Health Utilities for Children and Adults With Type 1 Diabetes. Medical Care. 49(10). 924–931. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mahesh Fuldeore Breakdown of academic impact, for papers by Wenke Hwang Breakdown of academic impact, for papers by Anuja Roy Breakdown of academic impact, for papers by Anita Burrell Breakdown of academic impact, for papers by Gérard de Pouvourville Breakdown of academic impact, for papers by Gregory S. Calip Breakdown of academic impact, for papers by Angie Mae Rodday Breakdown of academic impact, for papers by Neil Wintfeld Breakdown of academic impact, for papers by Roberta Ara Breakdown of academic impact, for papers by Sue Ward
Rankless by CCL
2026